Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Specialized Bioscience Research & Analysis

Active

Grant

Response Deadline02/09/2027, 04:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

UK Research and Innovation → Biotechnology and Biological Sciences Research Council (BBSRC)

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of 189488.

The full solicitation package (9 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

2026 to 2027 strategic Longer and Larger (sLoLa): full stage

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedNov 3

subcontract

Response DeadlineFeb 9

Submission deadline

Response Deadline

02/09/2027, 04:00:00 PM UTCin 3 months

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyUK Research and Innovation → Biotechnology and Biological Sciences Research Council (BBSRC)

ContactsNo contacts available

OfficeN/A

Organization / AgencyUK Research and Innovation → Biotechnology and Biological Sciences Research Council (BBSRC)

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Performs advanced biological research, laboratory analysis, and experimental validation for prime contractors on BBSRC bioscience discovery projects. Conducts curiosity-driven research using team science methodologies to advance the understanding of living systems. Utilizes high-throughput sequencing and advanced microscopy. Requires PhD/Post-doc credentials and institutional biosafety certifications. Delivers experimental data and peer-reviewed publications.

Similar Contracts

Same NAICS industry code

Immunohistochemical (IHC) Analysis SupportThe Immunohistochemical (IHC) Analysis Support subcontract, issued by the NASA Shared Services Center, involves providing specialized staining and chemical analysis of sectioned tissue for prime contractors on NASA Space Biosciences projects. The scope of work requires the application of antibodies and reagents to cryo-sectioned slides and the use of fluorescence microscopes and IHC staining stations to evaluate neuronal morphology. Due to the technical nature of the work, specialized training in neuro-histology is required to deliver the final analyzed slides and digital imaging reports. This opportunity is categorized under NAICS code 541714 and is associated with a performance location in zip code 94035. The solicitation was posted on November 4, 2026, with a response deadline of November 9, 2026.

NASA Shared Services Center

POSTED

about 15 hours ago

DEADLINE

Service request for specimen embedding and sectioning.

Solicitation # 80NSSC27948767Q

The NASA Shared Services Center is seeking custom histology research services to support a Space Biosciences Project evaluating neuronal morphology in mouse brains exposed to radiation, isolation, and simulated microgravity. The scope of work involves planning, preliminary testing, embedding, and cryo-sectioning of specific brain regions, including the substantia nigra, hippocampus, and prefrontal cortex. The contractor must provide slides with sections 15 microns thick, which are to be delivered to Principal Investigator Dr. Joshua Alwood within 90 days after receipt of order. Performance will be located at the NASA Ames Research Center. This procurement is being conducted under FAR Part 12 for commercial items and services, with the government intending to issue a sole source contract to ZYAGEN, identified as the sole provider of the required services. While the agency is currently requesting capability statements from interested organizations by November 9, 2026, to determine if a competitive procurement is feasible, it explicitly states that quotes will not be reviewed or accepted at this stage. Primary coordination for this effort is managed by Cara Craft and Will Garrett.

NASA Shared Services Center

POSTED

about 15 hours ago

DEADLINE

Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)

Solicitation # RFA-AI-28-014

The National Institutes of Health (NIH) issued solicitation RFA-AI-28-014 to establish centers focused on the systems-level understanding of the links between infectious pathogens, inflammatory pathways, and chronic diseases. The program supports two types of centers: Chronic and Infectious Diseases Systems Biology Centers (CIDSB), which examine the bidirectional link between chronic and infectious diseases, and Systems Biology Inflammation Centers (SBI), which focus on the role of inflammation in chronic diseases to identify precision medicine targets. The primary goals are to develop predictive computational models for disease progression, discover novel drug targets and biomarkers, and create harmonized, FAIR-compliant cross-disease datasets. The total program funding is 26 million dollars, with an expected 10 awards and an individual award ceiling of 2.5 million dollars. Applications must be submitted electronically via Grants.gov by February 18, 2027. The proposal structure is multi-component, requiring an overall section, an administrative core, a data and modeling core, and a biospecimen collection and processing core, with additional requirements for research projects and optional cores depending on the center type. Evaluation is based on an overall impact score focusing on significance and the qualifications of the investigators. Awardees must comply with strict cybersecurity incident reporting requirements, notifying the HHS awarding agency within 48 hours of discovery, and must adhere to rigorous biosafety and human subjects protection standards. Applicants must maintain active SAM registration and UEI identifiers to be eligible for funding.

National Institutes Of Health

POSTED

about 22 hours ago

DEADLINE

In Vivo Efficacy and Toxicology StudiesThis subcontract, titled In Vivo Efficacy and Toxicology Studies, supports the National Institutes of Health and the Department of Health and Human Services by providing preclinical validation of biologic therapies for prime contractors on NIH/NINDS ADRD projects. The scope of work involves executing in vivo efficacy, safety pharmacology, and toxicology studies utilizing translationally appropriate animal models specifically for Alzheimer's and Frontotemporal Dementia. To fulfill the requirements, the contractor must utilize GLP-compliant toxicology lab facilities to ensure regulatory standards are met. The primary deliverables include comprehensive preclinical validation reports and detailed toxicology data packages necessary for Investigational New Drug submission. The project is categorized under NAICS code 541714, with a response deadline set for October 10, 2028.

National Institutes Of Health

POSTED

DEADLINE

in almost 2 years

Genome Editing Construct and Delivery System OptimizationThis subcontract focuses on the design and optimization of genome editing constructs and biologic delivery systems to support prime contractors on NIH/NINDS genomic therapy projects. The scope of work involves utilizing CRISPR/Cas technology along with viral and non-viral vectors to refine editing constructs and delivery mechanisms. The selected provider will be responsible for assessing critical metrics including bioactivity, target engagement, durability, pharmacokinetics, and bioavailability. The final deliverables for this engagement consist of optimized therapeutic leads accompanied by comprehensive bioactivity and pharmacokinetics data reports.

National Institutes Of Health

POSTED

DEADLINE

in almost 2 years

NCI Research Specialist (Clinician Scientist)The NCI Research Specialist subcontract involves providing leadership and implementation services for National Cancer Institute funded clinical trials on behalf of prime contractors. The selected clinician scientist will be responsible for writing and revising protocols for national cancer clinical trials, managing trials within a clinical trials office, and recruiting patients. Additionally, the role requires active participation in NCI scientific review, monitoring, and steering committees. Candidates must possess clinician scientist status and demonstrated experience in cancer clinical research. The contract requires a dedicated effort ranging from 2.4 to 4.8 person-months per year. This opportunity is associated with the National Institutes of Health under the Department of Health and Human Services, with a response deadline set for February 20, 2029.

National Institutes Of Health

POSTED

DEADLINE

in over 2 years

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Solicitation # RFA-NS-28-012

The National Institutes of Health, under the Department of Health and Human Services, has issued solicitation RFA-NS-28-012 to support the translation of genome editing and biologic therapies for Alzheimer's Disease-Related Dementias (ADRD). This includes Frontotemporal Dementia, Lewy Body Dementias, Vascular Contributions to Cognitive Impairment and Dementia, and Multiple Etiology Dementias. The program funds the entire translational pipeline, from therapeutic lead optimization and drug product development to IND-enabling studies and early first-in-human clinical evaluations. Key activities include optimizing editing constructs and delivery systems, demonstrating in vivo efficacy, conducting safety pharmacology and toxicology studies, and developing scalable manufacturing processes that align with regulatory expectations. The agency intends to commit 6 million dollars in both fiscal years 2028 and 2029, with an expected three awards and a maximum project period of five years. Individual annual budget caps are set at 1.3 million dollars in direct costs, increasing to 2.5 million dollars for projects involving clinical trials. Awards are governed by the Public Health Service Act and federal regulations 42 CFR Part 52 and 2 CFR Part 200. Evaluation is based on an Overall Impact Score considering significance, innovation, approach, investigator expertise, and environment, with a specific focus on the Target Product Profile and the use of quantitative Go/No-Go milestones. Eligible applicants include small businesses and other for-profit organizations. Requirements for submission include active registration in the System for Award Management, a Unique Entity Identifier, and eRA Commons accounts. Awardees must adhere to strict cybersecurity incident reporting protocols, notifying the agency within 48 hours of discovery, and must register applicable clinical trials with ClinicalTrials.gov. The solicitation features multiple application cycles with deadlines extending through October 10, 2028, and earliest start dates ranging from December 2027 to July 2029.

National Institutes Of Health

POSTED

DEADLINE

in almost 2 years

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Solicitation # PAR-28-042

Solicitation PAR-28-042, issued by the National Institutes of Health under the Department of Health and Human Services, is a funding opportunity designed to support the analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer. The program focuses on tools for cancer detection, diagnosis, prognosis, monitoring, and the prediction of treatment response or toxicity. Funding is available through either a phased UH2/UH3 mechanism or a standalone UH3 mechanism to facilitate laboratory optimization and clinical validation using human samples. Key deliverables include the demonstration of assay results associated with clinical endpoints, the establishment of statistical cut-off values, and the definition of sensitivity and specificity. All clinical laboratories must adhere to CLIA, GLP, or ISO 17025 standards. Awards are determined via a peer review system based on an overall impact score, evaluating the importance of the research, rigor and feasibility of the approach, and the expertise of the investigators and their environment. Specific evaluation criteria include the clarity of milestones for transitioning from UH2 to UH3 phases and the adequacy of commercialization plans. Eligible applicants include small businesses, for-profit organizations, higher education institutions, and 501(c)(3) nonprofits. Applicants must maintain active registrations in SAM.gov, eRA Commons, and Grants.gov. Additionally, recipients must comply with strict cybersecurity incident reporting requirements, notifying the agency within 48 hours of discovery, and ensure all human subject protocols are reviewed by an Institutional Review Board or Independent Ethics Committee.

National Institutes Of Health

POSTED

DEADLINE

in about 3 years

2026 to 2027 strategic Longer and Larger (sLoLa): full stage

Solicitation # 189488

The Biotechnology and Biological Sciences Research Council (BBSRC), under UK Research and Innovation (UKRI), is soliciting proposals for the 2026 to 2027 Strategic Longer and Larger (sLoLa) program. This initiative funds large-scale, team-based, curiosity-driven bioscience discovery research projects aimed at achieving major breakthroughs in the fundamental understanding of living systems. Eligible projects must utilize a fully integrated team science approach, demonstrate a need for extended and large-scale funding, and enhance the overall capability and capacity of UK biosciences. Projects can last up to five years, and the full economic cost must exceed 2 million pounds, with BBSRC providing 80 percent of that cost. The selection process is conducted in two stages. The outline stage opened on April 16, 2026, and closed on June 25, 2026, with evaluations based on vision, approach, and team capability. Successful outline applicants are invited to the full stage, which opened on November 5, 2026, and closed on February 9, 2027. Full proposals are evaluated via external peer review and a multidisciplinary panel, focusing on management strategy and strategic case. Final funding recommendations are made by the Strategic LoLa Committee following an interview process with the highest-rated teams. All applications are managed through the UKRI Funding Service.

Biotechnology and Biological Sciences Research Council (BBSRC)

POSTED

DEADLINE

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Solicitation # PAR-28-042

The National Cancer Institute, under the National Institutes of Health, has issued solicitation PAR-28-042 to provide funding for the analytical and clinical validation of biomarkers and assays related to cancer. This initiative focuses on molecular, cellular, and imaging markers used for detection, diagnosis, prognosis, treatment response, prevention, and toxicity monitoring. The goal is to support laboratory optimization and validation for assays using human samples that address specific clinical needs and intended uses. Eligible projects may utilize either a standalone UH3 mechanism or a phased UH2/UH3 approach, though clinical trials are explicitly not allowed. The solicitation was posted on November 3, 2026, with a response deadline set for November 17, 2029.

National Cancer Institute

POSTED

DEADLINE

in about 3 years

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Solicitation # RFA-NS-28-012

The National Institute of Neurological Disorders and Stroke, under the National Institutes of Health, has issued solicitation RFA-NS-28-012 to support the translation of genome editing and biologic therapies for Alzheimer's Disease-Related Dementias. This initiative covers a broad range of conditions, including Frontotemporal Dementia, Lewy Body Dementias, Vascular Contributions to Cognitive Impairment and Dementia, and Multiple Etiology Dementias. The program is designed to advance the translational pipeline from initial therapeutic lead optimization and drug product development through IND-enabling studies and early clinical evaluation. Eligible activities include the optimization of delivery systems and editing constructs, the assessment of bioactivity and pharmacokinetics, and the demonstration of in vivo efficacy. Additionally, the funding supports safety pharmacology, toxicology studies, and the creation of scalable manufacturing processes and quality attributes that meet regulatory standards. This solicitation was posted on November 3, 2026, with a response deadline of October 11, 2028.

National Institute Of Neurological Disorders And Stroke

POSTED

DEADLINE

in almost 2 years

Insect Taxonomy and Identification SpecialistThis subcontract opportunity is for an Insect Taxonomy and Identification Specialist to support prime contractors on USDA Forest Health Protection projects through the Northern Research Station. The selected specialist will perform professional taxonomic screening and identification of raw insect trap samples, specifically focusing on species-level identification of wood-boring beetles and wood wasps, as well as identifying Coleoptera and select Hemiptera to the lowest taxonomic level. The work requires the use of taxonomic keys and high-powered microscopy, with final identification reports delivered in Word or PDF format. The solicitation was posted on November 2, 2026, with a response deadline of December 3, 2026. Classified under NAICS code 541714, the performance of this contract is associated with zip code 26505. Interested parties can find further details via the provided government workspace link.

Northern Research Station

POSTED

DEADLINE

More opportunities from UK Research and Innovation → Biotechnology and Biological Sciences Research Council (BBSRC)

Same awarding agency

Specialized Technical Research Support

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

High-Value Scientific Equipment Supply

Other Professional Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

International Travel Award Scheme for the Biological Sciences

Solicitation # 4599

POSTED

DEADLINE

Pre-announcement: Engineering Biology Programme: mission hubs

Solicitation # 205891

POSTED

DEADLINE

Research Equipment Maintenance ProviderThe Biotechnology and Biological Sciences Research Council, under UK Research and Innovation, is seeking a subcontracted Research Equipment Maintenance Provider to support grant recipients of the BBSRC ALERT 2026 program. The selected provider will be responsible for the technical support and preventative maintenance of installed research equipment, ensuring operational efficiency through scheduled visits, corrective repairs, troubleshooting, and software updates. All services must include calibration performed with proprietary diagnostic tools, the delivery of a signed service level agreement, and the maintenance of detailed service logs. This opportunity was posted on October 11, 2026, with a response deadline of January 14, 2027. The contract falls under NAICS code 811219 and is specifically designed to maintain high-level research infrastructure for biosciences. Interested parties should refer to the official UKRI opportunity link for further submission details.

Other Electronic and Precision Equipment Repair and Maintenance

POSTED

DEADLINE

Laboratory Equipment Installation ContractorThe Biotechnology and Biological Sciences Research Council, under UK Research and Innovation, is seeking a Laboratory Equipment Installation Contractor for a subcontract related to the BBSRC ALERT 2026 program. The selected contractor will be responsible for the physical installation and initial setup of research equipment for grant recipients. This scope of work includes unpacking, positioning, and assembling equipment, as well as connecting systems to essential power, gas, water, and data utilities to ensure a fully operational system. Beyond physical placement, the contractor must perform initial calibration and verification of operational status to deliver a turnkey equipment system. This opportunity was posted on October 11, 2026, and requires responses by January 14, 2027. The project falls under NAICS code 238990, focusing on specialized installation services for biosciences research equipment.

All Other Specialty Trade Contractors

POSTED

DEADLINE

Mid-Range Biosciences Research Equipment SupplierThe Biotechnology and Biological Sciences Research Council, under UK Research and Innovation, is seeking a subcontractor for the Mid-Range Biosciences Research Equipment Supplier contract. This initiative supports grant recipients of the BBSRC ALERT 2026 program by providing high-specification laboratory instrumentation specifically tailored for biotechnology and biological sciences. The selected supplier will be responsible for the manufacture and delivery of advanced, multi-user research equipment designed to serve a diverse range of research organizations, industry partners, and end-user communities. The procurement process for this subcontract began on October 11, 2026, with a response deadline set for January 14, 2027. Operating under NAICS code 334516, the contract focuses on the delivery of commissioned equipment that meets rigorous technical standards to facilitate high-level scientific research. Interested parties can find further details through the official UKRI opportunity portal.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Mid-range equipment for biosciences research: ALERT 2026

Solicitation # 205855

The ALERT 2026 scheme is an equipment-only grant administered by the Biotechnology and Biological Sciences Research Council under UK Research and Innovation. The program is designed to support the procurement of mid-range research equipment within the BBSRC remit, with a particular focus on advanced, multi-user equipment that benefits research organizations, industry, and end-user communities. Eligible equipment requests must fall into one of three categories: emerging and novel technologies, upgrading existing equipment to improve performance or capacity, or replacing obsolete workhorse equipment. Applications must be submitted via the UKRI Funding Service by January 14, 2027. Financial requirements specify a minimum equipment cost of 200,000 GBP, with all costs provided in GBP. The grant has a 12-month duration, during which all one-off installation expenses and service maintenance contracts must be paid. Applicants are required to provide an Equipment Classification Table in the purpose section and a Costs Summary Table in the resources and costs section of their application, as manufacturer and supplier quotes cannot be uploaded directly to the funding service.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

High-Performance Computing (HPC) and Cloud Hosting for BioscienceThis subcontract, issued by the Biotechnology and Biological Sciences Research Council under UK Research and Innovation, provides high-performance computing and cloud hosting for bioscience. The project focuses on supplying scalable computational infrastructure, including HPC clusters and cloud platforms such as AWS, Azure, and GCP, to host large-scale bioinformatics resources for lead research institutions involved in BBSRC 26BBR Fund projects. The provider is responsible for delivering a secure hosted environment for sensitive research data, ensuring full compliance with the UK National Security and Investment Act and Trusted Research and Innovation guidelines. Interested parties must submit their responses by November 19, 2026.

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

POSTED

about 2 months ago

DEADLINE

Biological Data Management and Quality AssuranceThis subcontract, titled Biological Data Management and Quality Assurance, supports lead research institutions on BBSRC 26BBR Fund projects under the Biotechnology and Biological Sciences Research Council. The scope of work involves comprehensive study-wide data management, including the creation of metadata and quality assurance for biological datasets. The contractor is responsible for implementing strict data security protocols, developing data sharing policies through metadata schemas, and ensuring all activities align with UKRI Data Management Plan templates and institutional security policies. Key deliverables for this engagement include curated datasets, detailed metadata catalogs, and a validated Data Management Plan. The opportunity was posted on September 15, 2026, with a response deadline of November 19, 2026. The project falls under NAICS code 541690 and is managed by UK Research and Innovation.

Other Scientific and Technical Consulting Services

POSTED

about 2 months ago

DEADLINE

Bioinformatics Resource Development and ImplementationThis subcontract, titled Bioinformatics Resource Development and Implementation, is issued by the Biotechnology and Biological Sciences Research Council under UK Research and Innovation. The project focuses on the development, implementation, and enhancement of bioinformatics software tools and biological resources for lead research institutions involved in BBSRC 26BBR Fund projects. The primary objective is to establish new resources and transition project-specific tools into community-based assets through the use of computational modeling tools, biological databases, and bioinformatics pipelines. The contractor is required to adhere to FAIR principles for data management to ensure that all deliverables are findable, accessible, interoperable, and reusable. The ultimate goal of the engagement is the delivery of a functional, community-accessible bioinformatics resource or software tool. Interested parties must submit their responses by the deadline of November 19, 2026, under NAICS code 541511.

Custom Computer Programming Services

POSTED

about 2 months ago

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS